Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Neste Corporation - Managers' Transactions, Lindfors (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 15 March 2022 at 6 p.m. (EET) Person subject to the notification requirementName: Lars Peter LindforsPosition: Other senior managerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14Notification type: INITIAL NOTIFICATIONReference number: 11424/7/6 ____________________________________________ Transaction date: 2022-03-15Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 2,483 Unit price: 0 EUR Aggregated transactions(

Neste Corporation - Managers' Transactions, Ståhlberg (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 15 March 2022 at 6 p.m. (EET) Person subject to the notification requirementName: Christian StåhlbergPosition: Other senior managerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14Notification type: INITIAL NOTIFICATIONReference number: 11427/7/6 ____________________________________________ Transaction date: 2022-03-15Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 2,208 Unit price: 0 EUR Aggregated transactions(

Neste Corporation - Managers' Transactions, Nyberg (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 15 March 2022 at 6 p.m. (EET) Person subject to the notification requirementName: Carl NybergPosition: Other senior managerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14Notification type: INITIAL NOTIFICATIONReference number: 11428/7/6 ____________________________________________ Transaction date: 2022-03-15Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 2,760 Unit price: 0 EUR Aggregated transactions(1):

Neste Corporation - Managers' Transactions, Aila (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 15 March 2022 at 6 p.m. (EET) Person subject to the notification requirementName: Minna AilaPosition: Other senior managerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14Notification type: INITIAL NOTIFICATIONReference number: 11431/6/6 ____________________________________________ Transaction date: 2022-03-15Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 2,572 Unit price: 0 EUR Aggregated transactions(1):

Neste Corporation - Managers' Transactions, Alonso (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 15 March 2022 at 6 p.m. (EET) Person subject to the notification requirementName: Mercedes AlonsoPosition: Other senior managerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14Notification type: INITIAL NOTIFICATIONReference number: 11433/7/6 ____________________________________________ Transaction date: 2022-03-15Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 2,937 Unit price: 0 EUR Aggregated transactions(1):

Neste Corporation - Managers' Transactions, Lange (receipt of a share-based incentive or remuneration)

Neste Corporation, Managers' Transactions, 15 March 2022 at 6 p.m. (EET) Person subject to the notification requirementName: Thorsten LangePosition: Other senior managerIssuer: Neste OyjLEI: 5493009GY1X8GQ66AM14Notification type: INITIAL NOTIFICATIONReference number: 11437/7/6 ____________________________________________ Transaction date: 2022-03-15Venue not applicableInstrument type: SHAREISIN: FI0009013296Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 2,585 Unit price: 0 EUR Aggregated transactions(1):

Atea ASA - share buyback

Oslo, 15 March On 15 March 2022, Atea ASA has purchased a total of 30,000 own shares at the Oslo Stock Exchange at an average price of NOK 136.72 per share. Following the completion of the above transactions, Atea ASA owns a total of 866,315 own shares, corresponding to 0.77% of Atea ASA's share capital. Additional information on the buyback program: Date on which the buyback program was announced: 11 February 2022 The duration of the buyback program: 14 February 2022 to 31 March 2022, or until the maximum number of shares has been repurchased. Size of the buyback program:

Change in the holding of Kesko Corporation's treasury shares

Kesko Corporation has today transferred a total of 14,400 of its own B shares (KESKOB) held by the Company as treasury shares to selected key persons who were included in the target group for the share plan RSP 2019 in accordance with the terms and conditions of the plan. The transfer of the shares is based on a decision by Kesko's Board of Directors, announced in a stock exchange release on 3 February 2022, to grant own B shares held by the Company in accordance with the terms and conditions of the share plan RSP 2019. The gross number of shares transferred today was 28,800 B shares

Svedberg's comment on mandatory bid from Stena Adactum

Svedbergs i Dalstorp ABs (publ) ("Svedbergs" or "the Company") main owner Stena Adactum AB ("Stena Adactum") has announced that they have acquired shares in Svedbergs. Through the acquisition, Stena Adactum has attained a direct and indirect holding of 10,847,075 shares of series B in Svedbergs, corresponding to a holding of approximately 30.7 per cent of the shares and votes in the Company. Through the acquisition, the mandatory bid threshold is passed, entailing that Stena Adactum is required to launch a mandatory takeover offer for the remaining shares in Svedbergs within four weeks from

Neste Corporation's disposal of own shares based on the share ownership plan

Neste Corporation, Stock Exchange Release, 15 March 2022 at 5 p.m. (EET) A total of 113,774 treasury shares of Neste Corporation has on 15 March 2022 been conveyed without consideration to the key persons participating in the Performance Share Plan 2019-2021 and in the Restricted Share Plan 2019-2021 of the share-based incentive program 2019 in accordance with the terms and conditions of the program. The decision of the Board of Directors on the share transfer is based on a share issue authorization granted by the Annual General Meeting of Shareholders on 18 May 2020. A total of 90

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(to besent to the relevantissuer and tothe FCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the EnQuest PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

Correction MAR label - Prostatype Genomics establishes subsidiary in the United States

The correction refers to the MAR label. This press release should be without the MAR label.Prostatype Genomics is now establishing a subsidiary in the USA, Prostatype Genomics, Inc., wholly owned 100% by Prostatype Genomics AB. It is an important step in the work towards the American market entry.Prostate cancer is today the second most common form of cancer among American men, and in 2022 it is estimated that almost 270,000 American men will be diagnosed with prostate cancer. A rapid establishment in the American market, together with commercial establishment in Europe, are Prostatype

Momentum Group publishes prospectus

Alligo AB (publ)’s (“Alligo”) subsidiary Momentum Group AB (publ) (“Momentum Group”) has today published the prospectus prepared ahead of the admission to trading of Momentum Group’s Class B shares on Nasdaq Stockholm.On 25 February 2022, Alligo announced that the Board of Directors had decided to propose that the shareholders of Alligo at the Extraordinary General Meeting on 23 March 2022 resolve to distribute all of Alligo's shares in Momentum Group to Alligo's shareholders and that Momentum Group's Class B shares are to be listed on Nasdaq Stockholm. In connection with the planned

Hansa Biopharma and German payer head association agree on reimbursement price for Idefirix[®] (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

· Hansa Biopharma completes the AMNOG reimbursement process for Idefirix[®] in Germany · Hansa and National Association of Statutory Health Insurance Funds (GKV-SV) agree on reimbursement price · German hospitals can receive extra funding for the final reimbursement price based on a positive NUB status 1 decision Lund, Sweden, March 15, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announces having reached an agreement on the reimbursement for Idefirix in Germany with the National Association of

Notice of Annual General Meeting 2022

(Corrected version) The annual general meeting of Aker BP ASA will be held on Tuesday 5 April 2022 at 09:00 CEST. The general meeting will be held as a digital meeting only, with no physical attendance for shareholders. Voting will be handled online during the meeting. Information about log-in details for the meeting is available in the notice of the general meeting. A guide for online participation is available on https://akerbp.com/general-meeting/. Please find attached the following documents: · Aker BP - Notice of Annual General Meeting 2022 - corrected.pdf 

Teleste´s Annual Report 2021 published

TELESTE CORPORATION  STOCK EXCHANGE RELEASE  15.3.2022 AT 16:00 EET TELESTE´S ANNUAL REPORT 2021 PUBLISHED   Teleste Corporation’s Annual Report 2021 and Financial Statements for the accounting period 1 January – 31 December 2021 and the Remuneration report have been published today in English and in Finnish on the company’s website at teleste.com/financial-reports   The Annual Report includes Board of Directors’ Report, Financial Statements and Auditors’ Report. Teleste has also published its Corporate Governance Statement 2021 separately from the Board of Directors’

Toivo Group Oyj - Managers' Transactions - Asko Myllymäki

Toivo Group Oyj - Managers' Transactions - 15 March 2022 at 4 p.m. ____________________________________________ Person subject to the notification requirement Name: Sirkka Myllymäki Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Asko Myllymäki Position: Member of the Board Issuer: Toivo Group Oyj LEI: 743700N31WYJDNPT8M98 Notification type: INITIAL NOTIFICATION Reference number: 11413/5/4 ____________________________________________ Transaction date: 2022-03-14 Venue: FIRST NORTH GROWTH MARKET

Norse Atlantic Airways secures London Gatwick slots and adapts launch plans

The current market situation is heavily impacted by the tragic events unfolding in Ukraine that have resulted in increased fuel prices and uncertainties relating to travel demand. To ensure that the Company enters the market at the right time, Norse has adjusted its launch of ticket sales and initial route offering; the company plans ticket sales to commence in April and first flight is expected to be in June 2022. At the same time, the Company has secured important slots at London Gatwick Airport.“The tragedy unfolding in Ukraine creates uncertainties within international air transport

Proposal from the Betsson’s Nomination Committee

For the Annual General Meeting 2022, re-election of Board members Johan Lundberg, Eva Leach, Pontus Lindwall and Peter Hamberg and new election of Eva de Falck, Louise Nylén and Tristan Sjöberg is proposed. Fredrik Carlsson has declined re-election. Johan Lundberg is proposed to be elected Chairman of the Board.Active ownership responsibility via board position There is a positive view in both Swedish society and among institutional investors that major shareholders are to take special responsibility by actively participating in the management of listed companies through a position on

Stora Enso’s Annual General Meeting and decisions by the Board of Directors

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 March 2022 at 15:45 EETStora Enso Oyj’s (Company) Annual General Meeting (AGM) was held on 15 March 2022 at the Company's Head Office in Helsinki, Finland. In order to prevent the spread of the Covid-19 pandemic, a shareholder or his/her proxy representative could not be present at the venue of the meeting. A total of 2 324 shareholders representing approximately 541 million shares and 199 million votes were represented at the meeting. The AGM supported all the proposals made by the Shareholders’ Nomination Board and the Board of Directors to the AGM

The subscription price for the exercise of warrants has been determined

The subscription price for subscription of new ordinary shares with series 4 (TO4) warrants in Quartiers Properties AB (publ) (“Quartiers” or the “Company”) has been set to SEK 3.71 per ordinary share.In total, there are 3,291,624 TO4 series 2020/2022 warrants. One (1) warrant entitles the holder to subscribe for one (1) new ordinary share in the Company during the period from 17 March 2022 to 31 March 2022. If fully exercised, the Company could receive approximately SEK 12 million.

Prostatype Genomics establishes subsidiary in the United States

Prostatype Genomics is now establishing a subsidiary in the USA, Prostatype Genomics, Inc., wholly owned 100% by Prostatype Genomics AB. It is an important step in the work towards the American market entry.Prostate cancer is today the second most common form of cancer among American men, and in 2022 it is estimated that almost 270,000 American men will be diagnosed with prostate cancer. A rapid establishment in the American market, together with commercial establishment in Europe, are Prostatype Genomics' focus areas. Fast and efficient road to market entryThe company's genetic test

ExpreS2ion publishes video from company presentation at Aktiespararna’s Aktiedagen

Hørsholm, Denmark, March 15, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed company presentation by CEO Bent U. Frandsen at the Aktiespararna Aktiedagen investor event on March 14, 2022 is now available on the company’s website.The presentation provides an update on ExpreS[2]ion’s powerful platform for vaccine development, updates on the pipeline and progress towards key catalysts. The presentation can be found on the Company’s investor website via the following link: https://investor.expres2ionbio.com/presentations/

Fooditive Sweetener: The Sweet Idea that Sparked a Plant-based Revolution, into a Novel Food Application in 2022

Rotterdam, the Netherlands, March 15, 2022 | Fooditive, a pioneer in developing plant-based ingredients, is gearing up for a game-changer in the industry: a Novel Food licence from the European Food Safety Authority (EFSA) for its sweetener. The Dutch company has developed from a concept to a company worth of 26 million euros in 2022 and is making significant progress. Founded on the belief that sustainability is more than a trend, Fooditive provides innovative and natural ingredients to food and beverage manufacturers.The company's unique process allows them to develop a remarkable

There are no items matching the current filter
There are no more items matching the current filter
Back to top